Lurking epidemic of hepatitis C virus infection in Iran: A call to action

Despite having a relatively low prevalence in the Iranian general population, the burden of hepatitis C virus (HCV) infection is on the rise, and hepatitis C is predicted to be the most important leading cause of viral hepatitis-related mortality in the near future in Iran. The recent population-bas...

Descripción completa

Detalles Bibliográficos
Autores principales: Taherkhani, Reza, Farshadpour, Fatemeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Letters To The Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583536/
https://www.ncbi.nlm.nih.gov/pubmed/28932350
http://dx.doi.org/10.4254/wjh.v9.i24.1040
_version_ 1783261339489140736
author Taherkhani, Reza
Farshadpour, Fatemeh
author_facet Taherkhani, Reza
Farshadpour, Fatemeh
author_sort Taherkhani, Reza
collection PubMed
description Despite having a relatively low prevalence in the Iranian general population, the burden of hepatitis C virus (HCV) infection is on the rise, and hepatitis C is predicted to be the most important leading cause of viral hepatitis-related mortality in the near future in Iran. The recent population-based epidemiological studies have revealed the predominant role of injecting drug use in increasing prevalence of HCV infection. Undoubtedly, new management paradigm is required to drive down the rising wave of hepatitis C in Iran. Priority should be given to young injecting drug users as the cornerstone of the lurking epidemic of HCV infection in Iran.
format Online
Article
Text
id pubmed-5583536
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-55835362017-09-20 Lurking epidemic of hepatitis C virus infection in Iran: A call to action Taherkhani, Reza Farshadpour, Fatemeh World J Hepatol Letters To The Editor Despite having a relatively low prevalence in the Iranian general population, the burden of hepatitis C virus (HCV) infection is on the rise, and hepatitis C is predicted to be the most important leading cause of viral hepatitis-related mortality in the near future in Iran. The recent population-based epidemiological studies have revealed the predominant role of injecting drug use in increasing prevalence of HCV infection. Undoubtedly, new management paradigm is required to drive down the rising wave of hepatitis C in Iran. Priority should be given to young injecting drug users as the cornerstone of the lurking epidemic of HCV infection in Iran. Baishideng Publishing Group Inc 2017-08-28 2017-08-28 /pmc/articles/PMC5583536/ /pubmed/28932350 http://dx.doi.org/10.4254/wjh.v9.i24.1040 Text en ©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Letters To The Editor
Taherkhani, Reza
Farshadpour, Fatemeh
Lurking epidemic of hepatitis C virus infection in Iran: A call to action
title Lurking epidemic of hepatitis C virus infection in Iran: A call to action
title_full Lurking epidemic of hepatitis C virus infection in Iran: A call to action
title_fullStr Lurking epidemic of hepatitis C virus infection in Iran: A call to action
title_full_unstemmed Lurking epidemic of hepatitis C virus infection in Iran: A call to action
title_short Lurking epidemic of hepatitis C virus infection in Iran: A call to action
title_sort lurking epidemic of hepatitis c virus infection in iran: a call to action
topic Letters To The Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583536/
https://www.ncbi.nlm.nih.gov/pubmed/28932350
http://dx.doi.org/10.4254/wjh.v9.i24.1040
work_keys_str_mv AT taherkhanireza lurkingepidemicofhepatitiscvirusinfectioniniranacalltoaction
AT farshadpourfatemeh lurkingepidemicofhepatitiscvirusinfectioniniranacalltoaction

Ejemplares similares